| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 124,958 | 118,848 | 154,688 | 245,973 | | Cost of Revenue | 93,933 | 88,028 | 110,667 | 152,283 | | | Gross Profit | 31,025 | 30,820 | 44,021 | 93,690 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,140 | 27,424 | 29,079 | 32,107 | | Non Recurring | 514 | 392 | 204,961 | 22,806 | | Others | 33,455 | 32,413 | 32,737 | 32,572 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (28,084) | (29,409) | (222,756) | 6,205 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,527) | 291 | 354 | 20,255 | | Earnings Before Interest And Taxes | (30,611) | (29,118) | (222,402) | 26,460 | | Interest Expense | 9,760 | 5,974 | 5,736 | 6,649 | | Income Before Tax | (40,371) | (35,092) | (228,138) | 19,811 | | Income Tax Expense | (15,046) | (13,856) | (45,313) | 15,881 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (25,325) | (21,236) | (182,825) | 3,930 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (25,325) | (21,236) | (182,825) | 3,930 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($25,325) | ($21,236) | ($182,825) | $3,930 |
|
0.29% Nasdaq 
Income Statement
